Improvement of Sleep Disorders During a Course of Radiotherapy for Breast Cancer - Final Results of the Prospective Interventional RADIO-SLEEP Trial

Copyright © 2022 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved..

BACKGROUND/AIM: Upcoming radiotherapy may cause distress and sleep disorders (SDO). This prospective interventional trial investigated SDO during a course of radiotherapy for breast cancer.

PATIENTS AND METHODS: Fifty patients were eligible. The primary endpoint was improvement of SDO after 15 fractions. Additional endpoints included SDO after 5 fractions and at the end of radiotherapy (EOT). Additional characteristics were analysed including use of smartphones/tablets, age, body mass index, performance score, comorbidity score, surgery, distress score, and emotional/ physical/practical problems.

RESULTS: After 15 fractions, 38% of patients reported improvement of SDO (p<0.0001). Improvement rates were 22% after 5 fractions (p=0.003) and 39% at EOT (p<0.0001). Moreover, a significant association was observed for lower distress score after 5 fractions.

CONCLUSION: Improvement of SDO occurred more often than expected, most likely due to habituation to radiotherapy. Since SDO did not improve in the majority of patients, timely psychological support should be offered to all patients.

Medienart:

E-Artikel

Erscheinungsjahr:

2022

Erschienen:

2022

Enthalten in:

Zur Gesamtaufnahme - volume:42

Enthalten in:

Anticancer research - 42(2022), 6 vom: 01. Juni, Seite 3085-3089

Sprache:

Englisch

Beteiligte Personen:

Rades, Dirk [VerfasserIn]
Narvaez, Carlos A [VerfasserIn]
Dziggel, Liesa [VerfasserIn]
Splettstösser, Laura [VerfasserIn]
Janssen, Stefan [VerfasserIn]
Olbrich, Denise [VerfasserIn]
Schild, Steven E [VerfasserIn]
Tvilsted, Søren [VerfasserIn]
Kjaer, Troels W [VerfasserIn]

Links:

Volltext

Themen:

Adjuvant radiotherapy
Breast cancer
Clinical Trial
Journal Article
Patient reported outcomes
Prospective trial
Sleep disorders

Anmerkungen:

Date Completed 02.06.2022

Date Revised 06.06.2022

published: Print

Citation Status MEDLINE

doi:

10.21873/anticanres.15796

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM341634433